Linking device features to patient outcomes

Medical device makers often struggle to evaluate how design choices affect safety and outcomes because registries, claims data, and small studies lack scale, timeliness, and device-level detail. Medical Components, Inc. (Medcomp) used Truveta Data to evaluate infection risks and usage trends across different hemodialysis catheter designs, comparing outcomes for its brands across multiple health systems. The analysis revealed meaningful differences in device performance and demographic risk that can guide product development and safety surveillance, demonstrating brand-to-brand comparisons not possible with claims or registry data alone. The page provides qualitative findings only; no specific numeric results are stated on the visible page.

Truveta is a real-world-data company owned by a consortium of major US health systems, supplying daily-updated de-identified EHR data and a genomic-linkage research program.

This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.